Morphoceuticals

Please join us in welcoming Associate Scientist Melissa Brown-Davis, Ph.D. to the Morphoceuticals team! Melissa has more than a decade of hands-on lab experience in cell signaling and molecular biology, with her prior research focused on developing proteomic networks and translating them into new signaling mechanisms. Melissa, your expertise will be a key asset as we work to build the first atlas of the #bioelectrome, and we’re thrilled to have you on board!

Our team is dedicated to assembling the first map of the #bioelectrome.    Meet Cathal McLoughlin, our Scientist responsible for the development of the high-performance tissue simulator used in in silico experiments involving artificial intelligence.   Cathal’s prior research focused on computational modeling of biologically realistic neural networks in Parkinson’s disease. He investigated how network architecture shapes global neural activity and, in turn, how neural activity influences network structure through neuroplasticity. His work was presented at several leading conferences, including NER, EMBC, and the Society for Neuroscience.    He is now leveraging that expertise to develop AI-assisted tools for exploring emergent bioelectric patterns in non-neural tissue. Thank you, Cathal, for powering our engine and driving us toward our goals every day!

Our CEO Jim Jenson, PhD, was featured in the latest edition of “Scrip Asks…What Does 2025 Hold for Biopharma?”   Alongside other key industry leaders, Jim shares his insights on the rise of #AI and the potential of tech-first approaches to power higher-level-omics and discoveries beneficial to human health.    Check out the full article: https://bit.ly/4jrJzcG

We’ve got a lot planned for this year:  ✅ Expanding our team ✅ Assembling the toolkit to build the first atlas of the bioelectrome ✅ Exploring partnerships with investors and scientific leaders who share our vision Join us!

With the end of the year upon us, the Morphoceuticals team is grateful for the continued support of our greater community. Through 2024 we welcomed our CEO, Jim Jenson, and our highly-skilled scientific team, built out our state-of-the-art lab space and made tremendous progress toward building the first atlas of the #bioelectrome.    We’re excited about what’s to come in 2025. 

We were excited to welcome Massachusetts Secretary of Economic Development Yvonne Hao, Undersecretary Sarah Stanton and MassVentures CEO Charlie Hipwood to the Morphoceuticals lab. It was great to show them our progress in building the first atlas of the bioelectrome and to learn more about their vision for ensuring the state remains the US hub for companies like ours. Thank you to the Massachusetts Executive Office of Economic Development (EOED) team for the visit, your interest and your commitment to a thriving life sciences industry.   

Are you looking to join a dynamic team that's building the first atlas of the bioelectrome? Morphoceuticals is #hiring an Associate Scientist of Regenerative Medicine Project Development to help contribute to our state-of-the-art research projects and drive groundbreaking advances in regenerative medicine. If you’re an experienced laboratory associate scientist looking for a unique growth opportunity, check out the full position details:

Our scientific co-founders recently came together to spotlight Morphoceuticals’ breakthrough approach to regenerative medicine. Check out our newly launched video featuring Drs. Michael Levin and David Kaplan to learn about their shared vision to create an atlas of the #bioelectrome to enable novel therapeutic discoveries. 

At Morphoceuticals, our team is working diligently to assemble the first map of the #bioelectrome.    Meet Nicolas Palacios Prado, our Senior Scientist. Nic has extensive experience in the field of bioelectrical intercellular communication. He spearheaded numerous research initiatives and is a recipient of the Howard Hughes Medical Institute International Research Fellowship and the Grass Fellowship at the Marine Biological Laboratory. Known for his expertise in electrical synapse plasticity and gap junction channels, Nicolas has made significant strides in understanding the intricate bioelectric networks and their modulation.    Nic, we are grateful for your steadfast commitment to unlocking the possibilities of regenerative medicine. Thanks for all that you do!

Morphoceuticals is featured in Genetic Engineering & Biotechnology News Magazine this month! Kathy Liszewski explores how adjusting a cell’s machinery could reverse aging’s clock. Our CEO, Dr. Jim Jenson discusses how understanding and manipulating bioelectric patterns could potentially allow us to rewrite them for the treatment of many conditions that are currently inadequately addressed by other modalities.    We are building the first atlas of the bioelectrome, the set of communication networks within the body that bind multi-cellular collectives together for a common purpose, maintaining tissue and organ level integrity and health. Our approach provides extraordinary opportunity to develop a higher-level-omics, above proteomics and transcriptomics, for novel discoveries beneficial to human health.    Read more here: https://bit.ly/3ZVyiKx